Suitable biomarkers for post-mortem differentiation of cardiac death causes: Quantitative analysis of miR-1, miR-133a and miR-26a in heart tissue and whole blood.

Biomarkers FFPE tissue MicroRNAs Myocardial infarction Quantitative analysis Sudden cardiac death Sudden infant death Sudden unexpected death Whole blood

Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
07 2023
Historique:
received: 20 09 2022
revised: 03 02 2023
accepted: 24 03 2023
medline: 16 6 2023
pubmed: 14 5 2023
entrez: 13 5 2023
Statut: ppublish

Résumé

Cardiovascular diseases are the most common causes of death worldwide. Cardiac death can occur as reaction to myocardial infarction (MI). A diagnostic challenge arises for sudden unexpected death (SUD) cases with structural abnormalities (SA) or without any structural abnormalities (without SA). Therefore, the identification of reliable biomarkers to differentiate cardiac cases from each other is necessary. In the current study, the potential of different microRNAs (miRNAs) as biomarkers in tissue and blood samples of cardiac death cases was analyzed. Blood and tissue samples of 24 MI, 21 SUD and 5 control (C) cases were collected during autopsy. Testing for significance and receiver operating characteristic analysis (ROC) were performed. The results show that miR-1, miR-133a and miR-26a possess a high diagnostic power to discriminate between different cardiac death causes in whole blood and in tissue.

Identifiants

pubmed: 37178622
pii: S1872-4973(23)00042-X
doi: 10.1016/j.fsigen.2023.102867
pii:
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0
MIRN1 microRNA, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102867

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Luise Mildeberger (L)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany. Electronic address: mildeberger@med.uni-frankfurt.de.

Julia Bueto (J)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.

Verena Wilmes (V)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.

Stefanie Scheiper-Welling (S)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.

Constanze Niess (C)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.

Elise Gradhand (E)

Institute of Pathology, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.

Marcel A Verhoff (MA)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.

Silke Kauferstein (S)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany. Electronic address: kauferstein@em.uni-frankfurt.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH